QIAGEN NV (QGEN)
34.74
-0.34
(-0.98%)
USD |
NYSE |
May 21, 10:24
QIAGEN Free Cash Flow : 403.87M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CDT Equity, Inc. | -17.96M |
| Thermo Fisher Scientific, Inc. | 6.748B |
| ICON plc | 971.25M |
| InflaRx NV | -44.56M |
| Adaptive Biotechnologies Corp. | -29.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 100.63M |
| Cash from Investing (Quarterly) | 211.47M |
| Cash from Financing (Quarterly) | -503.66M |
| Free Cash Flow Per Share (Quarterly) | 0.2496 |
| Free Cash Flow to Equity (Quarterly) | 217.96M |
| Free Cash Flow to Firm (Quarterly) | 60.91M |
| Free Cash Flow Yield | 5.59% |